$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

$avdl Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000101247717000046 Filed on August 09, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$46.31M	$38.86M
YoY Change	19.18%	-20.05%
Cost Of Revenue	$4.561M	$3.907M
YoY Change	16.74%	41.76%
Gross Profit	$41.75M	$34.95M
YoY Change	19.45%	-23.76%
Gross Profit Margin	90.15%	89.95%
Selling, General & Admin	$12.43M	$11.29M
YoY Change	10.09%	92.24%
% of Gross Profit	29.77%	32.3%
Research & Development	$6.792M	$7.604M
YoY Change	-10.68%	5.55%
% of Gross Profit	16.27%	21.76%
Depreciation & Amortization	$770.0K	$3.930M
YoY Change	-80.41%	20.18%
% of Gross Profit	1.84%	11.24%
Operating Expenses	$19.22M	$18.89M
YoY Change	1.73%	44.48%
Operating Profit	$34.13M	-$11.54M
YoY Change	-395.64%	387.05%
Interest Expense	-$30.00K	-$1.360M
YoY Change	-97.79%	-78.38%
% of Operating Profit	-0.09%
Other Income/Expense, Net	$1.670M	-$2.773M
YoY Change	-160.22%	-994.52%
Pretax Income	$36.30M	-$12.51M
YoY Change	-390.17%	49.79%
Income Tax	$7.370M	$7.449M
% Of Pretax Income	20.3%
Net Earnings	$28.93M	-$19.96M
YoY Change	-244.94%	18.39%
Net Earnings / Revenue	62.46%	-51.36%
Basic Earnings Per Share	$0.70	-$0.48
Diluted Earnings Per Share	$0.68	-$0.48
COMMON SHARES
Basic Shares Outstanding	41.09M shares	41.24M shares
Diluted Shares Outstanding	42.49M shares	41.24M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$173.8M	$154.9M
YoY Change	12.2%
Cash & Equivalents	$43.51M	$23.90M
Short-Term Investments	$130.3M	$131.0M
Other Short-Term Assets	$3.900M	$5.100M
YoY Change	-23.53%
Inventory	$5.747M	$3.640M
Prepaid Expenses	$3.061M	$3.457M
Receivables	$19.29M	$9.488M
Other Receivables	$1.600M	$4.600M
Total Short-Term Assets	$204.4M	$177.6M
YoY Change	15.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.328M	$3.104M
YoY Change	7.22%
Goodwill	$18.49M	$18.67M
YoY Change	-0.95%
Intangibles	$21.71M	$29.21M
YoY Change	-25.68%
Long-Term Investments
YoY Change
Other Assets	$8.242M	$5.661M
YoY Change	45.59%
Total Long-Term Assets	$54.81M	$72.06M
YoY Change	-23.94%
TOTAL ASSETS
Total Short-Term Assets	$204.4M	$177.6M
Total Long-Term Assets	$54.81M	$72.06M
Total Assets	$259.2M	$249.7M
YoY Change	3.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.32M	$7.043M
YoY Change	74.94%
Accrued Expenses	$30.34M	$10.59M
YoY Change	186.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$291.0K	$283.0K
YoY Change	2.83%
Total Short-Term Liabilities	$88.71M	$58.19M
YoY Change	52.45%
LONG-TERM LIABILITIES
Long-Term Debt	$594.0K	$788.0K
YoY Change	-24.62%
Other Long-Term Liabilities	$6.285M	$2.871M
YoY Change	118.91%
Total Long-Term Liabilities	$6.879M	$3.659M
YoY Change	88.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.71M	$58.19M
Total Long-Term Liabilities	$6.879M	$3.659M
Total Liabilities	$182.4M	$197.9M
YoY Change	-7.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$276.1M	-$304.5M
YoY Change	-9.33%
Common Stock	$389.9M	$375.2M
YoY Change	3.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.34M
YoY Change
Treasury Stock Shares	1.351M shares
Shareholders Equity	$76.73M	$51.84M
YoY Change
Total Liabilities & Shareholders Equity	$259.2M	$249.7M
YoY Change	3.79%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$28.93M	-$19.96M
YoY Change	-244.94%	18.39%
Depreciation, Depletion And Amortization	$770.0K	$3.930M
YoY Change	-80.41%	20.18%
Cash From Operating Activities	$8.230M	-$4.450M
YoY Change	-284.94%	-131.74%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	-$300.0K
YoY Change	-103.33%	-30.23%
Acquisitions
YoY Change
Other Investing Activities	$15.74M	-$8.820M
YoY Change	-278.46%	-166.32%
Cash From Investing Activities	$15.75M	-$9.120M
YoY Change	-272.7%	-170.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-12.95M	-410.0K
YoY Change	3058.54%	-96.2%
NET CHANGE
Cash From Operating Activities	8.230M	-4.450M
Cash From Investing Activities	15.75M	-9.120M
Cash From Financing Activities	-12.95M	-410.0K
Net Change In Cash	11.03M	-13.98M
YoY Change	-178.9%	-186.83%
FREE CASH FLOW
Cash From Operating Activities	$8.230M	-$4.450M
Capital Expenditures	$10.00K	-$300.0K
Free Cash Flow	$8.220M	-$4.150M
YoY Change	-298.07%	-128.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	avdl	Accrued Contract Research Organization AccruedContractResearchOrganization	1764000	USD
CY2017Q2	avdl	Accrued Contract Research Organization AccruedContractResearchOrganization	0	USD
CY2016Q4	avdl	Accrued Social Charges AccruedSocialCharges	794000	USD
CY2017Q2	avdl	Accrued Social Charges AccruedSocialCharges	924000	USD
CY2016Q4	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	7981000	USD
CY2017Q2	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	20496000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2016Q4	avdl	Advance To Suppliers And Other Current Assets AdvanceToSuppliersAndOtherCurrentAssets	1265000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4292000	USD
CY2017Q1	avdl	Share Premium Increase Decrease Adjustment SharePremiumIncreaseDecreaseAdjustment	-317254000	USD
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	32141000	USD
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	-20201000	USD
CY2017Q2	avdl	Advance To Suppliers And Other Current Assets AdvanceToSuppliersAndOtherCurrentAssets	814000	USD
CY2016Q4	avdl	Authorized Share Capital AuthorizedShareCapital	5500000	USD
CY2017Q2	avdl	Business Combination Financing Related Costs BusinessCombinationFinancingRelatedCosts	-1670000	USD
	avdl	Business Combination Financing Related Costs BusinessCombinationFinancingRelatedCosts	-2220000	USD
	avdl	Business Combinations Additions Made BusinessCombinationsAdditionsMade	22695000	USD
CY2017Q1	avdl	Distributable Reserves Increase Decrease Adjustment DistributableReservesIncreaseDecreaseAdjustment	317254000	USD
	avdl	Earn Out Payment EarnOutPayment	6572000	USD
	avdl	Earn Out Payment EarnOutPayment	665000	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	7769000	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	16515000	USD
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	4307000	USD
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	-2220000	USD
	avdl	Grants Recognized In Other Income And Income From Operations GrantsRecognizedInOtherIncomeAndIncomeFromOperations	70000	USD
	avdl	Grants Recognized In Other Income And Income From Operations GrantsRecognizedInOtherIncomeAndIncomeFromOperations	0	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	1630000	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	1175000	USD
CY2016Q2	avdl	License And Research Revenue LicenseAndResearchRevenue	693000	USD
	avdl	License And Research Revenue LicenseAndResearchRevenue	1556000	USD
CY2017Q2	avdl	License And Research Revenue LicenseAndResearchRevenue	-794000	USD
	avdl	License And Research Revenue LicenseAndResearchRevenue	-44000	USD
CY2016Q4	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	99000	USD
CY2017Q2	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	1132000	USD
CY2016Q4	avdl	Provision For Retirement Indemnity Noncurrent ProvisionForRetirementIndemnityNoncurrent	2431000	USD
CY2017Q2	avdl	Provision For Retirement Indemnity Noncurrent ProvisionForRetirementIndemnityNoncurrent	2577000	USD
CY2016Q4	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	1775000	USD
CY2017Q2	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	3039000	USD
	avdl	Royalty Payments For Related Party Financing Related Contingent Consideration RoyaltyPaymentsForRelatedPartyFinancingRelatedContingentConsideration	816000	USD
	avdl	Royalty Payments For Related Party Financing Related Contingent Consideration RoyaltyPaymentsForRelatedPartyFinancingRelatedContingentConsideration	0	USD
CY2016Q2	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	38165000	USD
	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	73518000	USD
CY2017Q2	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	47105000	USD
	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	98862000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001012477
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40084158	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	AVADEL PHARMACEUTICALS PLC
	dei	Trading Symbol TradingSymbol	AVDL
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	78000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	196000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7105000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	12321000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	228000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	746000	USD
CY2016Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	23898000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	101000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17839000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19285000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17222000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30339000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23565000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-22680000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	385020000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	389451000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4055000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3702000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7216000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	564000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1128000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6596000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6596000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4993000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5074000	shares
CY2016Q4	us-gaap	Assets Assets	245482000	USD
CY2017Q2	us-gaap	Assets Assets	259160000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	181186000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	204351000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	114980000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	130290000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1234000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1376000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1472000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1010000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	115218000	USD
CY2017Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	129924000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	54000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	65000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	12000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	32141000	USD
CY2017Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-13230000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-20201000	USD
CY2015Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	122693000	USD
CY2016Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	165521000	USD
CY2016Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	169347000	USD
CY2017Q1	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	153213000	USD
CY2017Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	127459000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	161000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65064000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23899000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39215000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43507000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-41165000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.122
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41371000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41435000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41371000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41435000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	414000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	414000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21887000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22209000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29638000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	55722000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3907000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7813000	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4561000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8463000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	50401000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	80913000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	12185000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	31351000	USD
CY2017Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-11156000	USD
CY2016Q4	us-gaap	Customer Refund Liability Noncurrent CustomerRefundLiabilityNoncurrent	905000	USD
CY2017Q2	us-gaap	Customer Refund Liability Noncurrent CustomerRefundLiabilityNoncurrent	1074000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2223000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2455000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	10342000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7432000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7110000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7681000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1611000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	34177000	USD
CY2017Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	43699000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2017Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	40615000	USD
CY2016Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	135170000	USD
CY2017Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	109514000	USD
CY2017Q2	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	86844000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	416000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	358000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.596
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.313
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.203
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.225
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.333
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.333
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.119
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.348
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.006
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.013
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.132
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.277
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.204
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.187
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.642
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.960
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.131
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.102
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.036
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.061
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.002
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10124000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11252000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2258000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1443000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2258000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2258000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2258000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32961000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32961000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6285000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22837000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21709000	USD
CY2016Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1680000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1261000	USD
CY2017Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	237000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-110000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016Q4	us-gaap	Goodwill Goodwill	18491000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	18491000	USD
CY2016Q4	us-gaap	Goodwill Gross GoodwillGross	18491000	USD
CY2017Q2	us-gaap	Goodwill Gross GoodwillGross	18491000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12509000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11255000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36297000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	70746000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7449000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14761000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7370000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15909000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1485000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3913000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	230000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	914000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1647000	USD
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3115000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	7399000	USD
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	13259000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4165000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3748000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4537000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	8843000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	8029000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	10800000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-4757000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-7232000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	453000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	681000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-39000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	125000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	451000	USD
CY2017Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	588000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-348000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4931000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1689000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1446000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	255000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	777000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	12747000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1461000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	232000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-5028000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	547000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	594000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	114980000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	322000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2345000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2489000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-270000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	80000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-546000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	264000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22837000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21709000	USD
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	263000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	438000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	263000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	526000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2429000	USD
CY2017Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4059000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	3258000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	5747000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	829000	USD
CY2017Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1688000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3223000	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1733000	USD
CY2016Q2	us-gaap	Investment Income Net InvestmentIncomeNet	390000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	590000	USD
CY2017Q2	us-gaap	Investment Income Net InvestmentIncomeNet	527000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	1579000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	203413000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	182432000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	245482000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259160000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62421000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	88709000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	36448000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-22421000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	268000	USD
CY2017Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	291000	USD
CY2017Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	130290000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-455000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	81000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7388000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13358000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50114000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16244000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15921000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	33536000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-19958000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26016000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	28927000	USD
	us-gaap	Net Income Loss NetIncomeLoss	54837000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11543000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5839000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	34126000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	67467000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3392000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1827000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7531000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8242000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2457000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2360000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	117000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	247000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1929000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3807000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	711000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	885000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-73000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-158000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-26000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-92000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	528000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1447000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	594000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	638000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-73000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-158000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-26000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-92000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	226000	USD
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1233000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5275000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6285000	USD
CY2016Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	374000	USD
CY2017Q2	us-gaap	Other Long Term Debt OtherLongTermDebt	178000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2773000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2220000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4307000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1670000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13081000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	0	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	1159000	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	2287000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	16315000	USD
CY2017Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	10854000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	19467000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	75528000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	67743000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	760000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	321000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5894000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5522000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3442000	USD
CY2017Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3061000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	376000	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	12000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	26013000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	51820000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3320000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3328000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7604000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12992000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6792000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13998000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	1069000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3722000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	3922000	USD
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	-200000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2017Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3922000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319800000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-276119000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	38858000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	75074000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	46311000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	98818000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11290000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20751000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12429000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24241000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4913000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4055000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	376000	USD
CY2017Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1351000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14338000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	42069000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	76728000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1200000	USD
CY2017Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1455000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1351000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	14338000	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-1261000	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-1304000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1565000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2456000	USD
CY2016Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	736000	USD
CY2017Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1059000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1396000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1392000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41241000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41241000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42487000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42625000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41241000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41241000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41091000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41233000	shares
CY2016Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	3291000	USD
CY2017Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	3170000	USD

Files In Submission

Name	View Source	Status
0001012477-17-000046-index-headers.html	Edgar Link	pending
0001012477-17-000046-index.html	Edgar Link	pending
0001012477-17-000046.txt	Edgar Link	pending
0001012477-17-000046-xbrl.zip	Edgar Link	pending
avdl-20170630.xml	Edgar Link	completed
avdl-20170630.xsd	Edgar Link	pending
avdl-20170630_cal.xml	Edgar Link	unprocessable
avdl-20170630_def.xml	Edgar Link	unprocessable
avdl-20170630_lab.xml	Edgar Link	unprocessable
avdl-20170630_pre.xml	Edgar Link	unprocessable
avdl2017q2.htm	Edgar Link	pending
exhibit311q22017.htm	Edgar Link	pending
exhibit312q22017.htm	Edgar Link	pending
exhibit321q22017.htm	Edgar Link	pending
exhibit322q22017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

2017 Q2 Form 10-Q Financial Statement

#000101247717000046 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL AVADEL PHARMACEUTICALS PLC Stock $avdl

2017 Q2 Form 10-Q Financial Statement

#000101247717000046 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl